Cellectis (CLLS) Shares Outstanding (Diluted) (2013 - 2026)
Powered by 
Analysis
Cellectis (CLLS) Shares Outstanding (Diluted) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Cellectis | 325.91 Mn | 159.06 Mn | - | 100.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.28 Mn |
| Mar 31, 2026 | 100.28 Mn |
| Dec 31, 2025 | 100.28 Mn |
| Sep 30, 2025 | 90.57 Mn |
| Jun 30, 2025 | 90.57 Mn |
| Mar 31, 2025 | 90.57 Mn |
| Dec 31, 2024 | 90.57 Mn |
| Sep 30, 2024 | 57.01 Mn |
| Jun 30, 2024 | 57.01 Mn |
| Mar 31, 2024 | 57.01 Mn |
| Dec 31, 2023 | 57.01 Mn |
| Sep 30, 2023 | 45.55 Mn |
| Jun 30, 2023 | 45.55 Mn |
| Mar 31, 2023 | 45.55 Mn |
| Dec 31, 2022 | 45.55 Mn |
| Sep 30, 2022 | 44.82 Mn |
| Jun 30, 2022 | 44.82 Mn |
| Mar 31, 2022 | 44.82 Mn |
| Dec 31, 2021 | 44.82 Mn |
| Sep 30, 2021 | 35.81 Mn |